U.S. markets closed

Werewolf Therapeutics, Inc. (HOWL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
18.31-1.68 (-8.40%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 7/21/2021
Current
Market Cap (intraday) 5
546.39M
Enterprise Value 3
464.17M
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 7
-17.99

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 324.16%
S&P500 52-Week Change 334.82%
52 Week High 323.99
52 Week Low 311.23
50-Day Moving Average 315.39
200-Day Moving Average 314.59

Share Statistics

Avg Vol (3 month) 3205.62k
Avg Vol (10 day) 365.4k
Shares Outstanding 527.57M
Implied Shares Outstanding 6N/A
Float 7.35M
% Held by Insiders 112.92%
% Held by Institutions 161.67%
Shares Short (Jun 29, 2021) 41.16M
Short Ratio (Jun 29, 2021) 47.56
Short % of Float (Jun 29, 2021) 46.05%
Short % of Shares Outstanding (Jun 29, 2021) 44.19%
Shares Short (prior month May 27, 2021) 4842.14k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -25.8M
Net Income Avi to Common (ttm)-126.84M
Diluted EPS (ttm)-115.11
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)84.6M
Total Cash Per Share (mrq)3.07
Total Debt (mrq)2.38M
Total Debt/Equity (mrq)2.89
Current Ratio (mrq)15.69
Book Value Per Share (mrq)-87.36

Cash Flow Statement

Operating Cash Flow (ttm)-22.55M
Levered Free Cash Flow (ttm)N/A